ライフサイエンスコーパス: isoflavone

1 avones, 2 flavonols, 2 phenylethanoids and 1 isoflavone).

2 Daidzein (1) is a natural estrogenic isoflavone.

3 o anticancer effects of genistein, a soybean isoflavone.

4 urce of macronutrients and phytochemicals as isoflavones.

5 cium, vitamin D, protein, potassium, and soy isoflavones.

6 ly because they are uniquely rich sources of isoflavones.

7 perature hardly affected the total amount of isoflavones.

8 ols and flavonols with soybean having mainly isoflavones.

9 entified as one of the up-regulated genes by isoflavones.

10 were screened as putative sources of dietary isoflavones.

11 ure of 30 degrees C was deleterious to grape isoflavones.

12 nd influences of dietary components, such as isoflavones.

13 plement based on soy germ containing 55.24mg isoflavones.

14 h, contain high levels of plant estrogens or isoflavones.

15 2DM treated with soy, either with or without isoflavones.

16 were tested while assaying soy glycosilated isoflavones.

17 as evaluated as potential tool to purify soy isoflavones.

18 ed the extractability of total phenolics and isoflavones.

19 thodology to extract, concentrate and purify isoflavones.

20 roved in EPs at 24 h (cfPWV change from 0 h: isoflavone, -0.2 +/- 0.2 m/s; placebo, 0.6 +/- 0.2 m/s;

21 3.48 ppb [95% CI, -5.99 to -0.97 ppb] vs soy isoflavones, 1.39 ppb [95% CI, -1.73 to 4.51 ppb]) did n

22 ither high-normal (73 mg/d) or low (10 mg/d) isoflavones, 2) soy foods with or without a prebiotic to

23 st (placebo, 1.98 [95% CI, 1.42-2.54] vs soy isoflavones, 2.20 [95% CI, 1.53-2.87]; positive values i

24 ntrol (placebo, 3.3 [95% CI, 2.7-4.1] vs soy isoflavones, 3.0 [95% CI, 2.4-3.7]), and changes in exha

25 the sum of individuals and 20% by F-C assay; isoflavones 36% and constituents with antioxidant activi

26 of soy isoflavone capsules (80 mg/d of total isoflavones, 51 mg/d aglucon units) on serum and tissue

27 reviously unreported compounds including two isoflavones 7,5'-dihydroxy-6,3'-dimethoxy-isoflavone-7-O

28 noside (4) and 7,5'-dihydroxy-6,3'-dimethoxy-isoflavone-7-O-(7,8-dihydro-p-hydroxycinnamoyl)-bet a-d-

29 wo isoflavones 7,5'-dihydroxy-6,3'-dimethoxy-isoflavone-7-O-beta-d-glucopyranoside (4) and 7,5'-dihyd

30 o furanonaphtoquinones, a furanochromone, an isoflavone, a stilbene and an iridoid).

31 excretion of glycitein compared to other soy isoflavones after a unique intake of food supplement bas

32 protein (18 g) + isoflavone tablets (105 mg isoflavone aglycone equivalents), soy protein + placebo

33 mg flavan-3-ols (90 mg epicatechin) + 100 mg isoflavones (aglycone equivalents)/d] or matched placebo

34 ection for the simultaneous determination of isoflavone aglycones (daidzein, glycitein and genistein)

35 sed a novel red clover extract (RCE) rich in isoflavone aglycones and probiotics to concomitantly pro

36 When isolating studies that provide isoflavone aglycones in their treatment arm, the average

37 Maximum conversion of beta-glucosides into isoflavone aglycones involved soaking the soybeans at 5

38 Isoflavone aglycones show higher bioavailability than th

39 ffects against bone loss may be enhanced for isoflavone aglycones.

40 alcitriol (25 mug/d) given either RCE (60 mg isoflavone aglycones/d and probiotics) or a masked place

41 olecules (glucose, sucrose, and pinitol) and isoflavone aglycons were increased but the isoflavones g

42 r the protective effect of soy is due to soy isoflavones alone or to their combination with other ben

43 Soy isoflavones, although not as potent as risedronate, are

44 ntribution of dietary food groups to urinary isoflavone and daidzein metabolite concentrations in a r

45 he objective was to examine whether combined isoflavone and flavan-3-ol intake alters vascular functi

46 After the 8-wk isoflavone and placebo period, whole-genome arrays were

47 ine the beneficial effects of a bioavailable isoflavone and probiotic treatment against postmenopausa

48 This study aimed to evaluate the isoflavone and total phenolic contents in kefir-fermente

49 After the fermentation and storage, the isoflavone and total phenolic contents were quantified b

50 rations of glycosylated, malonyl, and acetyl isoflavones and a corresponding increase in the concentr

51 evaluate changes in the phenolic compounds, isoflavones and antioxidant activity of soymilk followin

52 However, clinical research shows that isoflavones and estrogen exert differing effects on a va

53 Isoflavones and isoflavanones were mainly found in elici

54 rmented soymilk is a good source of aglycone isoflavones and phenolics, since the content of these su

55 beta-Glycosylated isoflavones and soyasaponin B-I were the most abundant c

56 ability, the potential biological effects of isoflavones and soyasaponins in infants should not be ov

57 e present study we determine the contents of isoflavones and soyasaponins in seven soy-based infant f

58 The mean contents of isoflavones and soyasaponins were 65.9mg/kg and 55.0mg/1

59 f the contents of different forms of soybean isoflavones and the effect of germination time on these

60 ole soybean flour (WSF) on the conversion of isoflavones and the inactivation of trypsin inhibitors.

61 e storage process did not alter the aglycone isoflavones and total phenolic contents.

62 Eleven isoflavones and two pterocarpan phytoalexins forms were

63 Applications to a natural flavone, isoflavone, and quinolone are shown.

64 ls such as retinoids, botanicals such as soy isoflavones, and even moisturizers and sunscreen.

65 soybeans had significantly higher TPC, total isoflavones, and peroxyl, hydroxyl, and ABTS(+) radical

66 Isoflavones are classified as both phytoestrogens and se

67 Soy-protein and isoflavones are dissociated by water rinsing and prolong

68 Soy isoflavones are naturally occurring phytochemicals with

69 Isoflavones are naturally occurring plant estrogens that

70 Isoflavones are plant-derived chemicals that are potenti

71 its, neither the effects, nor mechanisms, of isoflavones are well understood.

72 such as anthocyanins, proanthocyanidins, and isoflavones, are stored in the central vacuole, but the

73 Our findings reveal DIM and isoflavone as nontoxic activators of a miRNA that can bl

74 e and femoral neck for all studies providing isoflavones as aglycones.Twenty-six RCTs (n = 2652) were

75 pidemiological studies implicate dietary soy isoflavones as breast cancer preventives, especially due

76 he lentil samples with a standard mixture of isoflavones at three levels of fortification (5, 25 and

77 nd does not prenylate flavanone, flavone, or isoflavone backbones, even though it shares several comm

78 An isoflavone-based, commercially-available, dietary supple

79 marily animal protein and one containing soy isoflavones before and after menopause may result in com

80 ther, we assessed the effects of dietary soy isoflavones before or after ovariectomy.

81 able intestinal bacterial profile to enhance isoflavone bioavailability.

82 From a panel of phytoestrogen isoflavones, biochanin A (BCA) was identified as the mos

83 he metabolites of daidzein, a well known soy isoflavone, but its chemopreventive activity and the und

84 le aglycon appears to be the least extracted isoflavone by pressurized water.

85 The mean estimated intake of isoflavones by infants fed soy-based formulas was 0.8mg/

86 It was demonstrated that this isoflavone can cross the blood-brain barrier, making it

87 ontrolled trial to examine the effect of soy isoflavone capsules (80 mg/d of total isoflavones, 51 mg

88 One pool was rich in chain prenylated isoflavones (cIsf), one in chain prenylated stilbenoids

89 tive of this study is thus to identify a soy isoflavone combination with lower levels of daidzein and

90 For treatment with soy isoflavone combination, genistein was always better take

91 anipulation of beta-glycosidase activity and isoflavone composition can be used to modulate aglycone

92 (SIM) or almonds, and examined the impact of isoflavone composition in mediating conversion to aglyco

93 The isoflavone compounds activated the ISG54 promoter, media

94 ase reporter assay, we identified a class of isoflavone compounds that act as specific agonists of in

95 a new analytical method for determining five isoflavone compounds, three of which are aglycons, namel

96 ompounds and eleven bound phenolics in a soy isoflavone concentrate.

97 RCE significantly elevated the plasma isoflavone concentration (P < 0.05), the urinary 2-hydro

98 We describe the effects of soy isoflavone consumption on prostate specific antigen (PSA

99 erences in soy isoflavone intake by country, isoflavone consumption was inversely associated with rec

100 14% by Folin-Ciocalteu [F-C] method), total isoflavone content (22%) and total antioxidant activity

101 Total isoflavone content in commercial soy milk samples (n=8)

102 s, which is possibly related to the specific isoflavone content or the variable equol-producing capac

103 The determination of isoflavone content was performed by high-performance liq

104 The correlation of total isoflavone content with the phylogeny of this set of pla

105 central Italy and pulses for determining the isoflavone content, which was found to range from 1.1 to

106 tisus scoparius possessing the highest total isoflavones content (396 and 273 mg kg(-1), respectively

107 the effects of cooking and digestion on the isoflavone contents and bioactivities of the whole soy e

108 joint optimisation of the total phenolic and isoflavone contents as well as antioxidant activities: 0

109 vestigated for beta-glucosidase activity and isoflavone contents.

110 process parameters in obtaining the WSF with isoflavone conversions and reductions in trypsin inhibit

111 Compared to purified single isoflavones, cooked and digested soy were more effective

112 ural agents" [3,3'-diindolylmethane (DIM) or isoflavone] could affect the expression of miRNAs.

113 Here we show that the turmeric spice isoflavone curcumin suppresses p300 and CBP occupancy at

114 th supplements provided approximately 100 mg isoflavones/d (aglycone equivalents).

115 e soy intervention delivered 105.23 mg total isoflavones/d as genistein, daidzein, and glycitein in t

116 ventions that ranged from 52 to 220 mg total isoflavones/d increased bone calcium retention between 3

117 the pooled analysis, consumption of >/=10 mg isoflavones/d was associated with a nonsignificant reduc

118 stdiagnosis soy food consumption of >/=10 mg isoflavones/d was associated with a nonsignificant reduc

119 reported that equol, a metabolite of the soy isoflavone daidzein, may advance breast cancer potential

120 equol, a microbial-derived metabolite of the isoflavone daidzein, which is produced in the large inte

121 The photochemical behaviors of the isoflavones daidzein, formononetin, biochanin A, geniste

122 very, we discovered that an FDA-approved soy isoflavone, daidzein, improved stroke-induced behavioral

123 constant (K), time (tau(50)) in which 50% of isoflavone deglycosylation was reached, and time (tau(co

124 (tau(complete)) required to achieve complete isoflavone deglycosylation, were 0.16+/-0.02 min(-1), 4.

125 on of the malonyls-glucosides and glucosides isoflavone derivatives into glucosides or aglycons forms

126 e data suggest that short-term intake of soy isoflavones did not affect serum hormone levels, total c

127 the concern for consumers taking regular soy isoflavone dietary supplements.

128 rmine whether the acute vascular benefits of isoflavones differ according to EP phenotype and subsequ

129 The richest source of isoflavones, especially formononetin were sprouts cultiv

130 or 25 degrees C) to maximise the content of isoflavones, especially of high affinity for ERbeta.

131 in vitro and in vivo studies have shown that isoflavones exhibit anti-proliferative activity against

132 After 2 y of daily isoflavone exposure, all clinical chemistry values remai

133 olled intervention with a genistein-rich soy isoflavone extract (10mg/kg/day of genistein) followed b

134 samples obtained from cows that received the isoflavone extract-supplemented diet than from those tha

135 ture, contact time and solid liquid ratio on isoflavone extraction from soybean flour or Soybean Prot

136 s no significant difference (p>0.05) between isoflavone extraction in water and in 70% aqueous ethano

137 otein Isolate compared to soybean flour, the isoflavone extraction yield is 61%.

138 ne (total aglycone/total isoflavones) in SIM isoflavone extracts increased significantly in raw (35%)

139 p-nitrophenol-beta-d-glucopyranoside and SIM isoflavone extracts.

140 organic acids, and sugars) and 10 secondary (isoflavones, fatty acid methyl esters) metabolites.

141 s of phytochemicals, such as phenolic acids, isoflavones, flavones, flavonols and glucosinolates were

142 s were taken to be the contents of different isoflavone forms and the residual activity of trypsin in

143 During storage, there was a conversion of isoflavone forms to aglycones, being higher in heat-proc

144 red the content and profile of the different isoflavones forms.

145 een' extraction solvent for the isolation of isoflavones from okara, a by-product of soymilk producti

146 sed as a green alternative for separation of isoflavones from okara.

147 little is known about the bioavailability of isoflavones from whole soy food and their bioactivities

148 containing recombinant LaPT1 prenylated the isoflavone genistein at the B-ring 3' position to produc

149 The isoflavone genistein on the contrary to its well-establi

150 Finally, the ability of the isoflavone genistein to stimulate the growth of mammary

151 ufficient amounts of the predominant soybean isoflavone genistein.

152 trated that dietary daidzein or combined soy isoflavones (genistein, daidzein, and glycitein) increas

153 We found that treatment with the isoflavone, genistein, from 28-52 hours postfertilizatio

154 degrees C, promoted efficient hydrolysis of isoflavone glicosides to their aglycon forms.

155 d isoflavone aglycons were increased but the isoflavones glucoside content decreased in the greenhous

156 nation of several classes of phytochemicals (isoflavones, glucosinolates, flavones, flavonols and phe

157 or a safe and efficient process to hydrolyse isoflavone glycosides in soy molasses.

158 o spent coffee grounds for the conversion of isoflavone glycosides into their aglycones in black soym

159 s with formulations comprising predominantly isoflavone glycosides were included.Isoflavone treatment

160 dely used soy is a source of poorly absorbed isoflavones glycosides.

161 0.01 L (95% CI, -0.07 to 0.07 L) in the soy isoflavone group, which were not significantly different

162 nsisted of a placebo control group and 2 soy isoflavone groups (80 compared with 120 mg/d); women rec

163 ntation for 2 y with 80-120 mg soy hypocotyl isoflavones has minimal risk in healthy menopausal women

164 Isoflavones have an affinity for estrogen receptors (ERs

165 Soy isoflavones have antiestrogenic and anticancer propertie

166 Isoflavones have been associated with several health pro

167 The phytoestrogenic effects of isoflavones have led some to view soy foods and isoflavo

168 Soy isoflavones have variable effects on the prevention of p

169 Isoflavones, having chemical structures similar to estro

170 d to determine the effects of the content of isoflavones in a soy supplement and the equol-producing

171 n of beta-glucosidase and convert glycosidic isoflavones in aglycones.

172 Genistin and Daidzin were the major isoflavones in all samples.

173 of beta-conglycinin (7S), glycinin (11S) and isoflavones in heated soymilk.

174 ents for gaining insight into the effects of isoflavones in humans, especially with regard to the eff

175 wn to the safety of using high levels of soy isoflavones in humans, which is especially the concern f

176 method allowed reliable determinations of 12 isoflavones in less than 8 min of chromatographic elutio

177 Although some recent studies have detected isoflavones in natural waters, little is known about the

178 lular senescence signaling by SPI-associated isoflavones in osteoblastic cells may explain the persis

179 In evaluation of thermal stability of isoflavones in soymilk at 97 degrees C for 25min, the da

180 s of their equol-producing status, and mixed isoflavones in their natural ratios are more effective t

181 was a significantly higher extractability of isoflavones in UHT (about 38%) than in UHPH-treated samp

182 ein-rich soy supplement and 3 doses of mixed isoflavones in various proportions) and a bisphosphonate

183 for constitutive accumulation of prenylated isoflavones in white lupin.

184 percentage of aglycone (total aglycone/total isoflavones) in SIM isoflavone extracts increased signif

185 attributed to high soy diets, and major soy isoflavones, in particular daidzein and genistein, are t

186 In addition, isoflavones including daidzein and genistein were also c

187 The content of aglycone isoflavones increased 2-fold, and the total phenolic con

188 Total isoflavones increased with the higher combination of pre

189 nderlying the SPI-protective effects involve isoflavone-induced normalization of insulin signaling in

190 Soy isoflavone intake (mg/d) was measured with validated foo

191 Despite large differences in soy isoflavone intake by country, isoflavone consumption was

192 a precise definition of the safety level of isoflavone intake requires additional studies.

193 , 0.71) for the highest categories of soy or isoflavone intake versus the lowest.

194 verse associations were observed for dietary isoflavone intake.

195 thy participants, short-term flavan-3-ol and isoflavone intakes improve vascular function; however, t

196 Phytoestrogen isoflavone intervention to engage the neuroprotective ef

197 The interconversion of isoflavones into beta-glucosides was faster in UHT than

198 Daidzein, a soy isoflavone, is a clinically approved agent that has a ne

199 Biliatresone is an electrophilic isoflavone isolated from Dysphania species plants that h

200 , rodents fed soy-containing diets conjugate isoflavones less efficiently.

201 evious study indicated that soy protein with isoflavones lessened lumbar spine bone loss in midlife w

202 e data suggest that supplementation with soy isoflavone may be an effective treatment for patients wi

203 However, soy isoflavones may also have a role in promoting breast can

204 ough selective estrogen receptor modulation, isoflavones may exert beneficial effects against estroge

205 Isoflavones may mimic some effects of estrogen by bindin

206 Genistein, a natural, nontoxic dietary isoflavone, may be an advantageous therapeutic agent for

207 This may be due to differences in isoflavone metabolism.

208 The isoflavone metabolite equol was by far the predominant p

209 An isoflavone mixture similar to that found in serum of HF-

210 lavone supplement containing 100 mg of total isoflavones (n=193) or matching placebo (n=193) in 2 div

211 ty-six men were randomized to treatment with isoflavones (n=42) or placebo (n=44) for up to six weeks

212 arameters and contents of different forms of isoflavones of the seeds and soybean sprouts were evalua

213 Effects of isoflavones on adipose tissue gene expression were influ

214 ing results with regard to the effect of soy isoflavones on breast cancer risk.

215 pression did not affect the actions of E2 or isoflavones on p53 expression in either ST2 or OB6 cells

216 ce and the other with soy protein containing isoflavones, on protein markers of hippocampal bioenerge

217 gue, Czech Republic), containing 40% soybean isoflavones, on the contents of daidzein, glycitein, gen

218 ther stimulation of estrogenic signaling via isoflavones or through a novel and as yet uncharacterize

219 Interventions were 5 soy isoflavone oral supplements (2 doses of a genistein-rich

220 ily supplementation with 80 mg soy hypocotyl isoflavones over a 6-wk period had no effect on nitric o

221 contains only 18.07% of the original soybean isoflavones (p<0.001).

222 The pool enriched in chain prenylated isoflavones permeabilized the bacterial membrane within

223 e of this study was to determine whether soy isoflavone phase II metabolism differs between humans an

224 Consumption of protein powder and isoflavone pills did not differ between groups, and comp

225 or 120 mg aglycone equivalent soy hypocotyl isoflavones plus calcium and vitamin D on the health of

226 Gut bacterial modification of soy isoflavones produces metabolites that differ in biologic

227 ain storage on the functional properties and isoflavone profile of soy protein concentrate.

228 The isoflavone profile showed a decrease in the concentratio

229 No differences in the isoflavone profile were found, with beta-glucoside conju

230 either heat nor UHPH treatments affected the isoflavone profile, as the percentage of each chemical f

231 Changes of isoflavone profile, protein digestibility and lysine ava

232 perature treatment altered phenolic acid and isoflavone profiles; however, total isoflavones were una

233 Changes of isoflavones, protein digestibility and lysine availabili

234 ng or simmering time-dependently reduces the isoflavone:protein ratio in Tofu.

235 king soy-juice for 15 or 60min decreases the isoflavone:protein ratios in Tofu from 6.90 to 3.57 and

236 re reduced by ultra-filtration (6.54 vs 1.24 isoflavone:protein; p<0.001).

237 Ara h 8 binds the isoflavones quercetin and apigenin as well as resveratro

238 In contrast, the evidence that isoflavones reduce bone loss in postmenopausal women is

239 (rDau c 1.0104; rDau c 1.0201; rDau c 4; the isoflavone reductase-like proteins rDau c IFR 1, rDau c

240 A discussion on the changes in isoflavones related to temperature and time is reported.

241 Isoflavones, reported to have beneficial effects on huma

242 Isoflavone-rich diets are associated with reduced menopa

243 At 20 degrees C both isoflavones rose until the end of the experiment, reachi

244 ones (SPI) or 15 g soy protein alone without isoflavones (SP) daily for three months.

245 ed with 15 g soy protein containing 66 mg of isoflavones (SPI) or 15 g soy protein alone without isof

246 ipants were randomly assigned to receive soy isoflavone supplement containing 100 mg of total isoflav

247 not significantly improve more with the soy isoflavone supplement than with placebo.

248 d different soy foods, pure genistein, or an isoflavone supplement was <1% in steady state and <2% at

249 taking a controller medication, use of a soy isoflavone supplement, compared with placebo, did not re

250 Isoflavone supplementation did not affect blood lymphocy

251 d after control for pretreatment values, soy isoflavone supplementation had no effect on arginine flu

252 luate the clinical outcomes of soy hypocotyl isoflavone supplementation in healthy menopausal women a

253 The objective was to test the effect of soy isoflavone supplementation on nitric oxide production an

254 LG isoflavone supplementation resulted in a caloric restric

255 The efficacy of soy isoflavone supplementation to stimulate nitric oxide pro

256 spite numerous clinical trials of short-term isoflavone supplementation, there is a paucity of data r

257 nd plasma lipid profile were not affected by isoflavone supplementation.

258 Isoflavone supplements also consistently alleviate menop

259 Soy isoflavone supplements are used to treat several chronic

260 flavones have led some to view soy foods and isoflavone supplements as alternatives to conventional h

261 ffects of an 8-wk consumption of 2 different isoflavone supplements compared with placebo on whole-ge

262 aised concern that soy foods, and especially isoflavone supplements, are contraindicated for patients

263 Isoflavone supplements, consumed by women experiencing m

264 nthesis was silenced via RNA interference of isoflavone synthase in soybean hairy root composite plan

265 4 intervention groups: soy protein (18 g) + isoflavone tablets (105 mg isoflavone aglycone equivalen

266 protein + placebo tablets, control protein + isoflavone tablets, and control protein + placebo tablet

267 Genistein is a phytoestrogen isoflavone that exerts agonist and antagonist effects on

268 Genistein is a soy isoflavone that has antitumor activity both in vitro and

269 atio of 20 to 1 and 20 degrees C, 47% of the isoflavones that can be extracted with 70% aqueous ethan

270 ystematic review and meta-analysis examining isoflavone therapies and bone mineral density (BMD) loss

271 ndomized controlled trials (RCTs) evaluating isoflavone therapies for treating BMD loss at the lumbar

272 was to optimise conversion of beta-glucoside isoflavones to aglycones in soymilk processing and to ev

273 The affinity of isoflavones to ERs was evaluated by molecular modelling

274 enhance chemical and enzymatic conversion of isoflavones to their aglycone forms.

275 stein, glycetin, secoisolariciresinol, total isoflavones, total lignans, and total phytoestrogens wer

276 estradiol, PSA, and total cholesterol in the isoflavone-treated group compared to men receiving place

277 For the femoral neck (18 RCTs, n = 1604), isoflavone treatment showed a significantly (P < 0.01) h

278 At the lumbar spine, isoflavone treatment was associated with a significantly

279 The effect appears dependent on whether isoflavone treatments are in aglycone form; we conclude

280 minantly isoflavone glycosides were included.Isoflavone treatments exert a moderately beneficial effe

281 c acids, 5 flavones, 4 phenylethanoids and 1 isoflavone; V. polita: 10 flavones, 5 phenolic acids, 2

282 c acids, 2 phenylethanoids, 1 flavonol and 1 isoflavone; V. spuria: 10 phenolic acids, 5 flavones, 2

283 The content of isoflavones was determinate by ultra performance liquid

284 while no consistent increase of the four soy isoflavones was determined.

285 entions such as dietary and supplemental soy isoflavones were associated with improvement in daily ho

286 Flavonols and isoflavones were associated with seed coats and less tha

287 Estrogenic isoflavones were found, in the 1940s, to disrupt ewe rep

288 Furthermore, isoflavones were highly associated with seed maturity on

289 ralolide and flavonoids such as flavones and isoflavones were identified.

290 oratory and animal studies reported that soy isoflavones were major bioactive compounds in soy to exe

291 sis, cell cycles and cellular uptakes of the isoflavones were measured after 48 h.

292 Saponins, flavonols and isoflavones were quantified in sprouts, cotyledons and s

293 Soy-juice isoflavones were reduced by ultra-filtration (6.54 vs 1.

294 acid and isoflavone profiles; however, total isoflavones were unaffected.

295 ral products 3,3'-diinodolylmethane (DIM) or isoflavone, which increased miR-146a expression, caused

296 Soy protein is rich in isoflavones, which are a class of potential estrogenic a

297 ermentation was more efficient in converting isoflavones with M. purpureus NRRL 1992.

298 Bioavailable isoflavones with selective estrogen receptor affinity sh

299 g increase in the concentrations of aglycone isoflavones, with the magnitude of these changes increas

300 We hypothesized that isoflavones would alter behavior and physiology of rats